1-(3-Methylbenzoyl)-4-[5-(trifluoromethyl)pyridin-2-yl]piperazine

Catalog No. :
ACQZTS735
CAS No. :
941189-17-9
Molecular Formula :
C18H18F3N3O
Molecular Weight :
349.36

IUPAC Name:m-tolyl(4-(5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)methanone

1-(3-Methylbenzoyl)-4-[5-(trifluoromethyl)pyridin-2-yl]piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Methylbenzoyl)-4-[5-(trifluoromethyl)pyridin-2-yl]piperazine
IUPAC Namem-tolyl(4-(5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)methanone
MDL No.MFCD00170232
Molecular FormulaC18H18F3N3O
Molecular Weight349.36
SMILESFC(C1=CN=C(N2CCN(C(C3=CC=CC(C)=C3)=O)CC2)C=C1)(F)F
InChI KeySBWQWRIXBWJMFK-UHFFFAOYSA-N
Synonym3-METHYLPHENYL 4-(5-(TRIFLUOROMETHYL)(2-PYRIDYL))PIPERAZINYL KETONE;1-(3-methylbenzoyl)-4-[5-(trifluoromethyl)pyridin-2-yl]piperazine;Methanone, (3-methylphenyl)[4-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazinyl]-
CAS No.941189-17-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQZTS735 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBJTY052 route compound structure diagram
    ACBJTY05299-04-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQZTS735 route product structure diagram
    ACQZTS735941189-17-9
Inquiry

2. ACQZTS735 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQZTS735 route product structure diagram
    ACQZTS735941189-17-9
Inquiry

Comments (0)